Skip to Content

Adalimumab-afzb (Subcutaneous)

Subcutaneous route(Solution)

Serious InfectionsIncreased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens.Discontinue adalimumab-afzb if a patient develops a serious infection or sepsis during treatment.Perform test for latent TB; if positive, start treatment for TB prior to starting adalimumab-afzb.Monitor all patients for active TB during treatment, even if initial latent TB test is negative.MalignancyLymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF-blockers including adalimumab products.Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have occurred in adolescent and young adults with inflammatory bowel disease treated with TNF-blockers including adalimumab products .

Commonly used brand name(s)

In the U.S.

  • ABRILADA

Pharmacologic Class: Adalimumab

Uses for adalimumab-afzb

Adalimumab-afzb injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 4 years of age and older for juvenile idiopathic arthritis. Adalimumab-afzb is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-afzb may be used alone or in combination with other medicines (eg, methotrexate).

Adalimumab-afzb injection is also used to treat the symptoms of active Crohn's disease in adult patients who have not been helped by other medicines, including infliximab. It is also used to treat moderate to severe ulcerative colitis in patients who have been treated with other medicines (eg, azathioprine, corticosteroids, or 6-mercaptopurine) that did not work well.

Adalimumab-afzb injection is also used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away.

Adalimumab-afzb is available only with your doctor's prescription.

Before using adalimumab-afzb

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For adalimumab-afzb, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to adalimumab-afzb or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of adalimumab-afzb injection for the treatment of juvenile idiopathic arthritis in children 4 years of age and older. However, safety and efficacy have not been established in children younger than 2 years of age or weighing less than 10 kilograms (kg) for juvenile idiopathic arthritis. Safety and efficacy have not been established for other uses in children.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of adalimumab-afzb injection in the elderly. However, adalimumab-afzb may cause serious infections and cancer more often in the elderly, which may require caution in patients receiving adalimumab-afzb.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking adalimumab-afzb, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using adalimumab-afzb with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

  • Abatacept
  • Adenovirus Vaccine
  • Anakinra
  • Bacillus of Calmette and Guerin Vaccine, Live
  • Cholera Vaccine, Live
  • Dengue Tetravalent Vaccine, Live
  • Infliximab
  • Influenza Virus Vaccine, Live
  • Measles Virus Vaccine, Live
  • Mumps Virus Vaccine, Live
  • Poliovirus Vaccine, Live
  • Rilonacept
  • Rotavirus Vaccine, Live
  • Rubella Virus Vaccine, Live
  • Smallpox Vaccine
  • Tofacitinib
  • Typhoid Vaccine
  • Varicella Virus Vaccine, Live
  • Yellow Fever Vaccine
  • Zoster Vaccine, Live

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other medical problems

The presence of other medical problems may affect the use of adalimumab-afzb. Make sure you tell your doctor if you have any other medical problems, especially:

  • Blood problems (eg, aplastic anemia, pancytopenia, thrombocytopenia), history of or
  • Congestive heart failure or
  • Guillain-Barré syndrome, history of or
  • Infections (fungal, bacterial), history of or
  • Leukopenia (low number of white blood cells) or
  • Multiple sclerosis or
  • Optic neuritis (eye problem) or
  • Psoriasis (skin disease)—Use with caution. May make these conditions worse.
  • Cancer, active or history of or
  • Chronic obstructive pulmonary disease (COPD)—Use with caution. May increase the chance of getting new cancers.
  • Diabetes or
  • Hepatitis B, history of or
  • Opportunistic infections, history of or
  • Tuberculosis, history of—May increase chance for side effects.
  • Infection, active—Should not be used in patients with this condition.
  • Tuberculosis, active—Should be treated first before receiving adalimumab-afzb.

Proper use of adalimumab-afzb

Adalimumab-afzb is given as a shot under your skin in the upper thighs or stomach. It may sometimes be given at home to patients who do not need to be in the hospital or clinic. If you are using adalimumab-afzb at home, your doctor or nurse will teach you how to prepare and inject the medicine. Be sure that you understand how to use adalimumab-afzb. Adalimumab-afzb is given as a shot under your skin in the upper thighs or stomach. It may sometimes be given at home to patients who do not need to be in the hospital or clinic. If you are using adalimumab-afzb at home, your doctor or nurse will teach you how to prepare and inject the medicine. Be sure that you understand how to use adalimumab-afzb.

Adalimumab-afzb comes with a Medication Guide and patient instructions. Read and follow these instructions carefully. Ask your doctor if you have any questions.

If you use adalimumab-afzb at home, you will be shown the body areas where this shot can be given. Use a different body area each time you give yourself or your child a shot. Keep track of where you give each shot to make sure you rotate body areas. This will help prevent skin problems. Do not inject into skin areas that are red, bruised, tender, hard, or scaly, or areas with scars or stretch marks.

Allow 15 to 30 minutes for the medicine to warm up to room temperature. Do not remove the needle cover while allowing the medicine to reach to room temperature. Remove it before use.

Check the liquid in the syringe. It should be clear and colorless to pale brown. Do not use the syringe if it is cloudy, discolored, or has particles in it.

Dosing

The dose of adalimumab-afzb will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of adalimumab-afzb. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For injection dosage forms (prefilled syringe or pen):
    • For Crohn's disease:
      • Adults—At first (Day 1), 160 milligrams (mg) injected under the skin (four 40 mg injections in one day or two 40 mg injections a day for two days in a row). Then 2 weeks later (Day 15), a dose of 80 mg is given. A maintenance dose of 40 mg is given at week 4 (Day 29) and every other week thereafter.
      • Children—Use and dose must be determined by your doctor.
    • For juvenile idiopathic arthritis:
      • Children 4 years of age and older and
        • weighing 30 kilograms (kg) or more—40 milligrams (mg) injected under the skin every other week.
        • weighing 15 kg to less than 30 kg—20 mg injected under the skin every other week.
        • weighing 10 to less than 15 kg—10 mg injected under the skin every other week.
      • Children younger than 4 years of age weighing less than 30 kg—Use and dose must be determined by your doctor.
    • For plaque psoriasis:
      • Adults—At first, 80 milligrams (mg) injected under the skin, then 40 mg 1 week after the initial dose and every other week thereafter.
      • Children—Use and dose must be determined by your doctor.
    • For rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis:
      • Adults—40 milligrams (mg) injected under the skin every other week. Your doctor may adjust your dose as needed.
      • Children—Use and dose must be determined by your doctor.
    • For ulcerative colitis:
      • Adults—At first (Day 1), 160 milligrams (mg) injected under the skin (four 40 mg injections in one day or two 40 mg injections a day for two days). Then 2 weeks later (Day 15), a dose of 80 mg is given. A maintenance dose of 40 mg is given at week 4 (Day 29) and every other week thereafter.
      • Children—Use and dose must be determined by your doctor.

Missed dose

If you miss a dose of adalimumab-afzb, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Store in the refrigerator. Do not freeze.

Keep it in its original container. Protect from light. You may also store adalimumab-afzb at room temperature for up to 30 days. Do not store it in extremely cold or hot temperatures. Throw away any unused medicine after 30 days.

Throw away used syringes or pens in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.

Precautions while using adalimumab-afzb

It is very important that your doctor check your or your child's progress at regular visits to make sure adalimumab-afzb is working properly. Blood tests may be needed to check for unwanted effects.

You or your child will need to have a skin test for tuberculosis before you start using adalimumab-afzb. Tell your doctor if you or anyone in your home has ever had a positive reaction to a tuberculosis skin test.

Adalimumab-afzb injection will lower the number of some types of blood cells in your body. Because of this, you may bleed or get infections more easily. To help with these problems, avoid being near people who are sick or have infections. Wash your hands often. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers.

Adalimumab-afzb may cause other unwanted effects that may not occur until months or years after adalimumab-afzb is used. A small number of people (including children and teenagers) who have used this type of medicine have developed certain types of cancer (eg, leukemia). Some patients also developed a rare type of cancer called lymphoma. Talk with your doctor if you or your child have unusual bleeding, bruising, or weakness, swollen lymph nodes in the neck, underarms, or groin, or unexplained weight loss. Also, check with your doctor right away if your skin has red, scaly patches, or raised bumps that are filled with pus.

Adalimumab-afzb injection may cause serious allergic reactions, including anaphylaxis. Check with your doctor right away if you or your child have a rash, itching, hoarseness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after using adalimumab-afzb.

Check with your doctor right away if you or your child have more than one of these symptoms: swelling of the face, fingers, feet, or lower legs, or sudden weight gain. These may be signs of a heart condition called congestive heart failure (CHF).

Some people who have used adalimumab-afzb developed lupus-like symptoms during treatment and got better after the medicine was stopped. Check with your doctor right away if you or your child start having chest pains, joint pain, or a rash on your cheeks or arms that is sensitive to the sun.

Do not have any live vaccines (immunizations) while you or your child are being treated with adalimumab-afzb. Your child's vaccines need to be current before he or she begins using adalimumab-afzb. Be sure to ask your child's doctor if you have any questions about this.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Adalimumab-afzb side effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

  • Bladder pain
  • bloody or cloudy urine
  • chest pain
  • chills
  • cough
  • difficult, burning, or painful urination
  • ear congestion or pain
  • fever
  • frequent urge to urinate
  • head congestion
  • headache
  • hoarseness or other voice changes
  • lower back or side pain
  • pain or tenderness around the eyes and cheekbones
  • sneezing
  • sore throat
  • stuffy or runny nose
  • tightness of the chest
  • troubled breathing

Less common

  • Blurred vision
  • difficulty with moving
  • dizziness
  • muscle pain or stiffness
  • nervousness
  • pain in the joints
  • pounding in the ears
  • slow or fast heartbeat

Incidence not known

  • Blindness
  • blistering, peeling, or loosening of the skin
  • decreased urine output
  • decreased vision
  • diarrhea
  • dilated neck veins
  • extreme fatigue
  • eye pain
  • irregular breathing
  • irregular heartbeat
  • itching
  • red, irritated eyes
  • red skin lesions, often with a purple center
  • sores, ulcers, or white spots in the mouth or on the lips
  • swelling of the face, fingers, feet, or lower legs
  • unusual tiredness or weakness
  • weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.